Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.
Hepatitis C virus (HCV) infection, which results in chronic hepatitis C (CHC) in most patients (70-85%), is a major cause of liver disease and remains a major therapeutic challenge. The mechanisms determining liver damage and the key factors that lead to a high rate of CHC remain imperfectly understood. The precise role of cytoskeletal (CS) proteins in HCV infection remains to be determined. Some studies including our recent study have demonstrated that changes occur in the expression of CS proteins in HCV-infected hepatocytes. A variety of host proteins interact with HCV proteins. Association between CS and HCV proteins may have implications in future design of CS protein-targeted therapy for the treatment for HCV infection. This chapter will focus on the interaction between host CS and viral proteins to signify the importance of this event in HCV entry, replication and transportation.
Liver-Biliary-Pancreatic Center, Carolinas Medical Center, and School of Medicine, University of North Carolina, Carolinas Medical Center, Charlotte, NC, USA. sriparna.ghosh1@gmail.com
Sriparna
S
Ghosh
Keith J
KJ
Kaplan
Laura W
LW
Schrum
Herbert L
HL
Bonkovsky
D000818:Animals; D001693:Biological Transport, Active / Q000502:physiology; D003598:Cytoskeletal Proteins / Q000096:biosynthesis*; D016174:Hepacivirus / Q000502:physiology*; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology / Q000821:virology; D054884:Host-Pathogen Interactions / Q000502:physiology*; D006801:Humans; D008099:Liver / Q000378:metabolism* / Q000821:virology; D014764:Viral Proteins / Q000378:metabolism*; D053586:Virus Internalization; D014779:Virus Replication / Q000502:physiology
D003598:Cytoskeletal Proteins; D014764:Viral Proteins